Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'

NCT04653194 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Biktarvy
DRUG: Symtuza

Sponsor

Chelsea and Westminster NHS Foundation Trust

Collaborators

[object Object]
[object Object]